Japan's Patent Office plans to submit an amendment to the patent lawnext January so that it can raise maximum fines for infringements from 5 million yen to 100 million yen ($860,070) or more.
Agency officials told the Kyodo News Service that this would help motivate domestic companies to invest in R&D.
The Office is also considering reviewing the formula for assessing damages paid by companies infringing patent rights, to pave the way for patent-right holders to seek higher damages in civil law suits.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze